Altaviva (Medtronic) is the newest option in tibial nerve stimulation for urge urinary incontinence — and it represents a significant step forward for California patients who want ongoing tibial neuromodulation therapy without weekly office visits. Here is what San Diego OAB patients should know about this new device.
What Is Altaviva?
Altaviva is a rechargeable, leadless implantable neurostimulator designed to deliver automatic, continuous tibial nerve stimulation for urge urinary incontinence. Unlike office-based PTNS, which requires weekly in-office sessions indefinitely, Altaviva is implanted once and provides ongoing therapy without returning to the office for treatment sessions.
The device is placed in a small pocket in the deep fascia near the medial ankle — superior to the medial malleolus and anterior to the Achilles tendon. The procedure is minimally invasive and typically outpatient.
FDA Approval and Indication
The Altaviva system received FDA approval on September 18, 2025, for the treatment of urge urinary incontinence in patients who have failed or could not tolerate more conservative treatments. This makes it a third-line therapy option, consistent with the treatment tier at which sacral neuromodulation and bladder Botox are applied.
Device Features
Per Medtronic's device description, Altaviva features: rechargeable design with approximately 15-year battery life, leadless construction (simpler than traditional implantable neurostimulators), automatic therapy delivery, and periodic recharging. These are manufacturer claims and individual outcomes may vary.
Important Coverage Note for California Patients
FDA approval does not automatically create Medicare or commercial insurance coverage. As of the time of publication, there is no Medicare National Coverage Determination (NCD) or Local Coverage Determination (LCD) specifically applicable to the Altaviva implant. California Medicare claims (Noridian) are reviewed case-by-case. Commercial coverage through Aetna, Blue Cross, Cigna, and UnitedHealthcare is being established as evidence accumulates. California Bladder verifies current coverage status for each San Diego patient individually before recommending Altaviva. Call (858) 571-3630.
This article is for informational purposes only and does not constitute medical advice. Coverage information is general; individual plan requirements vary. A clinical evaluation is required.